The trial of the astrageneracic vaccine has been suspended due to adverse reactions in the body of a volunteer in Britain.
Every major vaccine manufacturers are trying to make a successful vaccine for novel coronavirus as early as possible. AstraZeneca PLC is ahead in this race.
But in their vaccine trial, one of the participants reportedly had a serious adverse reaction after being vaccinated. AstraZeneca has since temporarily suspended the final phase of their vaccine trial. The incident took place in Britain. AstraZeneca's CEO Pascal Soriot said,
The woman's diagnosis has not been confirmed yet, but she is improving and will likely be discharged from the hospital as early as today.
A spokesman for AstraZeneca also said that the vaccine was discontinued to review safety data in accordance with the standard review process. Researchers at AstraZeneca and Oxford Universities in Britain and other countries are working together to develop the vaccine.
The symptom of the volunteer is still unknown. According to latest reports, the participant is expected to recover fully. As a result, clinical trials of other vaccine manufacturers have also stalled. They are also checking to see if the same bad reaction is happening to their vaccines.
Meanwhile, nine US and European vaccine companies said on Tuesday that they would work to meet the criteria for testing their vaccines, conducting scientific tests and testing their suitability.